Augmentation with antidepressants in schizophrenia treatment: benefit or risk
- PMID: 25834445
- PMCID: PMC4370910
- DOI: 10.2147/NDT.S62266
Augmentation with antidepressants in schizophrenia treatment: benefit or risk
Abstract
We focused on the application of antidepressants in schizophrenia treatment in this review. Augmentation of antidepressants with antipsychotics is a common clinical practice to treat resistant symptoms in schizophrenia, including depressive symptoms, negative symptoms, comorbid obsessive-compulsive symptoms, and other psychotic manifestations. However, recent systematic review of the clinical effects of antidepressants is lacking. In this review, we have selected and summarized current literature on the use of antidepressants in patients with schizophrenia; the patterns of use and effectiveness, as well as risks and drug-drug interactions of this clinical practice are discussed in detail, with particular emphasis on the treatment of depressive symptoms in schizophrenia.
Keywords: antipsychotics; depressive symptoms; drug-drug interaction.
Figures
References
-
- Hausmann A, Fleischhacker WW. Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review. Acta Psychiatr Scand. 2002;106:83–96. - PubMed
-
- Möller H-J. Drug treatment of depressive symptoms in schizophrenia. Clin Schizophr Relat Psychoses. 2008;1:328–340.
-
- Siris SG, Bench C. Depression and Schizophrenia. In: Hirsch SR, Weinberger DR, editors. Schizophrenia. Oxford: Blackwell Science Ltd; 2007. pp. 142–167.
-
- Freudenreich O, Tranulis C, Cather C, Henderson DC, Evins AE, Goff DC. Depressive symptoms in schizophrenia outpatients – prevalence and clinical correlates. Clin Schizophr Relat Psychoses. 2008;2:127–135.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
